UnitedHealth Group Incorporated $UNH is Panagora Asset Management Inc.'s 9th Largest Position

Key Points

• Panagora Asset Management Inc. increased its stake in UnitedHealth Group by 93.8% in Q1, acquiring an additional 246,321 shares, bringing its total ownership to 508,849 shares.
• UnitedHealth Group reported an earnings miss for Q2 with an EPS of $4.08, falling short of the consensus estimate of $4.45 and achieving revenue of $111.62 billion.
• Institutional investors now hold 87.86% of UnitedHealth Group's stock, indicating strong support from investment firms.

Panagora Asset Management Inc. boosted its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 93.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 508,849 shares of the healthcare conglomerate's stock after buying an additional 246,321 shares during the period. UnitedHealth Group makes up 1.3% of Panagora Asset Management Inc.'s holdings, making the stock its 9th biggest holding. Panagora Asset Management Inc. owned about 0.06% of UnitedHealth Group worth $266,510,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. Citizens National Bank Trust Department increased its position in shares of UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after acquiring an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH lifted its stake in shares of UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after buying an additional 1,465 shares in the last quarter. Caitlin John LLC lifted its stake in UnitedHealth Group by 14.8% in the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock worth $451,000 after purchasing an additional 111 shares in the last quarter. Sherbrooke Park Advisers LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $515,000. Finally, Full Sail Capital LLC raised its holdings in UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock worth $815,000 after buying an additional 33 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on UNH. Oppenheimer decreased their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. TD Securities reaffirmed a "hold" rating and set a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Wells Fargo & Company reduced their target price on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Piper Sandler cut their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Finally, JPMorgan Chase & Co. cut their price target on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a report on Wednesday, August 6th. Fifteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $353.00.

UnitedHealth Group Stock Up 2.5%

UnitedHealth Group stock traded up $7.48 during midday trading on Monday, hitting $309.77. 12,018,847 shares of the company's stock were exchanged, compared to its average volume of 18,891,168. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a market cap of $280.55 billion, a PE ratio of 13.42, a P/E/G ratio of 2.00 and a beta of 0.44. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a 50-day moving average of $288.16 and a two-hundred day moving average of $379.63.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the prior year, the business posted $6.80 earnings per share. The firm's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio is currently 38.30%.

Insider Buying and Selling

In related news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.28% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.